These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3145267)

  • 1. Interaction between piperacillin and pefloxacin or amikacin on the selection of resistant mutants of Pseudomonas aeruginosa.
    Boisivon A; Guiomar C; Gutmann L
    J Antimicrob Chemother; 1988 Nov; 22(5):651-7. PubMed ID: 3145267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzymologic aspect of piperacillin combinations].
    Labia R; Morand A; Verchere-Beaur C; Amrani R; Beklahia C
    Presse Med; 1986 Dec; 15(46):2303-8. PubMed ID: 2949272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
    Van der Auwera P; Husson M; Klastersky J
    J Antimicrob Chemother; 1988 Jan; 21(1):49-55. PubMed ID: 3128521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S; Sawa A; Kamiya A; Mizuno H
    J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method].
    Uete T; Matsuo K
    Jpn J Antibiot; 1990 Sep; 43(9):1572-8. PubMed ID: 2124633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Piperacillin-amikacin combinations: killing curves].
    Chanal M; Sirot J; Chanal C; Cluzel M; Sirot D; Joly B
    Pathol Biol (Paris); 1990 Sep; 38(7):682-9. PubMed ID: 2122398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    Lagast H; Pascual-Lopez A; Dejace P; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    J Antimicrob Chemother; 1991 Jul; 28(1):25-34. PubMed ID: 1769941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
    Vojtová V; Kolár M; Hricová K; Uvízl R; Neiser J; Blahut L; Urbánek K
    New Microbiol; 2011 Jul; 34(3):291-8. PubMed ID: 21811750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC; Marchou B; Michéa-Hamzehpour M; Auckenthaler R
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():11-8. PubMed ID: 3086276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Hirano L; Yih J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.